Since increased Tim-3 expression can negatively regulate Th1 cell responses and decrease inflammation-induced organ damage, the higher expression in patients with SLE may reflect in part a compensatory response to the inflammation in SLE. Here, HAVCR2 is linked to systemic lupus erythematosus.